Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results - Nasdaq

Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial ResultsNasdaqPresented the results from the GeneSight GUIDED randomized controlled trial at the American Psychiatric Association annual meeting.

Pages

Subscribe to Green Pharmacy RSS